Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis;Biopsia del ganglio centinela después de la quimioterapia neoadyuvante en pacientes con cáncer de mama operable y ganglios axilares positivos al diagnóstico

Revista Espanola de Medicina Nuclear e Imagen Molecular

Volumn 32, Issue 4, 2013, Pages 240-245

  Rebollo Aguirre, A C ^a   Gallego Peinado, M ^b   Sanchez Sanchez R ^a   Pastor Pons, E ^a   Garcia Garcia J ^a   Chamorro Santos, C E ^a   Menjon Beltran S ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA LUCÍA   (Spain)

Author keywords

Axillary lymph node dissection; Breast cancer; C ncer de mama; Ganglio centinela; Linfadenectom a axilar; Neoadjuvant chemotherapy; Quimioterapia neoadyuvante; Sentinel lymph node

Indexed keywords

ALBUMIN TC 99M; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER SIZE; CANCER STAGING; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 84879270463     PISSN: 2253654X     EISSN: 22538070     Source Type: Journal    
DOI: 10.1016/j.remn.2013.03.006     Document Type: Article

References (30)

1. Mieog J.S., van de Velde C.J. Neoadjuvant chemotherapy for early breast cancer. Expert Opin Pharmacother 2009, 10:1423-1434.
2. Bernet L., Piñero A., Vidal-Sicart S., Cano R., Cordero J.M., Giménez J., et al. Actualización del consenso sobre la biopsia selectiva del ganglio centinela en el cáncer de mama. Rev Senología Patol Mam 2010, 23:201-208. Sociedad Española de Senología y Patología Mamaria.
3. Dixon J.M., Cody H.S. Role of sentinel node biopsy in patients having neoadjuvant chemotherapy. Eur J Surg Oncol 2010, 36:511-513.
4. Piñero A., Giménez J., Vidal-Sicart S., Intra M. Selective sentinel lymph node biopsy and primary systemic therapy in breast cancer. Tumori 2010, 96:17-23.
5. Sabel M.S. Sentinel lymph node biopsy before or after neoadjuvant chemotherapy: Pros and cons. Surg Oncol Clin N Am 2010, 19:519-538.
6. Shimazu K., Noguchi S. Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer. Surg Today 2011, 41:311-316.
7. D'Angelo-Donovan D.D., Dickson-Witmer D., Petrelli N.J. Sentinel lymph node biopsy in breast cancer: A history and current clinical recommendations. Surg Oncol 2012, 21:196-200.
8. Newman E.A., Sabel M.S., Nees A.V., Schott A., Diehl K.M., Cimmino V.M., et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 2007, 14:2946-2952.
9. Lee S., Kim E.Y., Kang S.H., Kim S.W., Kim S.K., Kang K.W., et al. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 2007, 102:283-288.
10. Ozmen V., Unal E.S., Muslumanoglu M.E., Igci A., Canbay E., Ozcinar B., et al. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol 2010, 36:23-29.
11. Canavese G., Dozin B., Vecchio C., Tomei D., Villa G., Carli F., et al. Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes. Eur J Surg Oncol 2011, 37:688-694.
12. Chintamani, Tandon M., Mishra A., Agarwal U., Saxena S. Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer-a prospective study. World J Surg Oncol 2011, 9:19.
13. Kang E., Chung I.Y., Han S.A., Kim S.M., Jang M., Lyou C.Y., et al. Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy. J Breast Cancer 2011, 14:147-152.
14. Alvarado R., Yi M., Le-Petross H., Gilcrease M., Mittendorf E.A., Bedrosian I., et al. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 2012, 19:3177-3184.
15. Thomas S., Prakash A., Goyal V., Popli M.B., Agarwal S., Choudhury M. Evaluation of sentinel node biopsy in locally advanced breast cancer patients who become clinically node-negative after neoadjuvant chemotherapy: A preliminary study. Int J Breast Cancer 2011, 2011:870263. doi:10.4061/2011/870263.
16. Takei H, Yoshida T, Kurosumi M, Inoue K, Matsumoto H, Hayashi Y, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation Int J Clin Oncol. doi:10.1007/s10147-012-0418-4.
17. Rebollo-Aguirre Á.C., Gallego-Peinado M., Menjón-Beltrán S., García-García J., Pastor-Pons E., Chamorro-Santos C.E., et al. Biopsia del ganglio centinela en pacientes con cáncer de mama operable tratadas con quimioterapia neoadyuvante. Rev Esp Med Nucl Imagen Mol 2012, 31:117-123.
18. Kim T., Giuliano A.E., Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: A metaanalysis. Cancer 2006, 106:4-16.
19. Tan V.K., Goh B.K., Fook-Chong S., Khin L.W., Wong W.K., Yong W.S. The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer-A systematic review and meta-analysis. J Surg Oncol 2011, 104:97-103.
20. Boughey J.C., Suman V.J., Mittendorf E.A., Ahrendt G.M., Wilke L.G., Taback B., et al. The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy-results from the ACOSOG Z1071 trial. Cancer Res 2012, 72:94s.
21. Kuehn T., Bauerfeind I.G.P., Fehm T., Fleige B., Helms G., Lebeau A., et al. Sentinel lymph node biopsy before or after neoadjuvant chemotherapy-Final results from the prospective german, multiinstitutional SENTINA-trial. Cancer Res 2012, 72:95s.
22. Chung A., Giuliano A. Axillary staging in the neoadjuvant setting. Ann Surg Oncol 2010, 17:2401-2410.
23. Lee M.C., Joh J.E., Chau A. Axillary staging prior to neoadjuvant chemotherapy: The roles of sentinel lymph node biopsy and axillary ultrasonography. Cancer Control 2012, 19:277-285.
24. Shigekawa T., Sugitami I., Takeuchi H., Misumi M., Nakamiya N., Sugiyama M., et al. Axillary ultrasound examination is useful for selecting patients optimally suited for sentinel lymph node biopsy after primary systemic chemotherapy. Am J Surg 2012, 204:487-493.
25. Hunt K.K., Yi M., Mittendorf E.A., Guerrero C., Babiera G.V., Bedrosian I., et al. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 2009, 250:558-566.
26. Sakakibara M., Nagashima T., Kadowaki M., Onai Y., Fujimori T., Yokomizo J., et al. Clinical significance of axillary microresiduals after neoadjuvant chemotherapy in breast cancer patients with cytologically proven metastases. Ann Surg Oncol 2009, 16:2470-2478.
27. Solá M., Alberro J.A., Fraile M., Santesteban P., Ramos M., Fabregas R., et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: Final results from the multicenter clinical trial AATRM 048/13/2000. Ann Surg Oncol 2013, 20:120-127.
28. Ruano Pérez R., Gómez-Caminero López F., Ramos Boyero M., Rosero Enríquez A.S., Díaz González L.G., Tamayo Alonso P., et al. La biopsia del ganglio centinela en la estadificación de cáncer de mama tratado con quimioterapia neoadyuvante. Rev Esp Med Nucl Imagen Mol 2012, 31:5.
29. Moral Duarte A., Duch Renom J., Pérez García J.I., Tibau Martorell A., Lupu I., Estorch Cabrera M., et al. Ganglio centinela tras quimioterapia neoadyuvante del cáncer de mama. Resultados 2 años después de la validación de la técnica. Cir Esp 2012, 90:316-317.
30. Grupo Español de Investigación en Cáncer de Mama (GEICAM). Estudio prospectivo de validación de la biopsia selectiva del ganglio centinela en pacientes con carcinoma de mama no inflamatorio tras recibir tratamiento sistémico primario. Estudio GEICAM-2005/07 [consultado 10 Feb 2013]. Disponible en: http://www.geicam.org/.